questionsmedicales.fr
Tumeurs
Tumeurs par type histologique
Tumeurs épithéliales épidermoïdes et glandulaires
Tumeurs kystiques, mucineuses et séreuses
Cystadénocarcinome
Cystadénocarcinome : Questions médicales fréquentes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome : Questions médicales les plus fréquentes",
"headline": "Cystadénocarcinome : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cystadénocarcinome : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-01",
"dateModified": "2025-03-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs kystiques, mucineuses et séreuses",
"url": "https://questionsmedicales.fr/mesh/D018297",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs kystiques, mucineuses et séreuses",
"code": {
"@type": "MedicalCode",
"code": "D018297",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome mucineux",
"alternateName": "Cystadenocarcinoma, Mucinous",
"url": "https://questionsmedicales.fr/mesh/D018282",
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome mucineux",
"code": {
"@type": "MedicalCode",
"code": "D018282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590.480.225"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome papillaire",
"alternateName": "Cystadenocarcinoma, Papillary",
"url": "https://questionsmedicales.fr/mesh/D018283",
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome papillaire",
"code": {
"@type": "MedicalCode",
"code": "D018283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590.480.230"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome séreux",
"alternateName": "Cystadenocarcinoma, Serous",
"url": "https://questionsmedicales.fr/mesh/D018284",
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome séreux",
"code": {
"@type": "MedicalCode",
"code": "D018284",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590.480.240"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome",
"alternateName": "Cystadenocarcinoma",
"code": {
"@type": "MedicalCode",
"code": "D003536",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hui Liu",
"url": "https://questionsmedicales.fr/author/Hui%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Ao Wang",
"url": "https://questionsmedicales.fr/author/Ao%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Gynecology and Obstetrics, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Yushan Ma",
"url": "https://questionsmedicales.fr/author/Yushan%20Ma",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Min Sun",
"url": "https://questionsmedicales.fr/author/Min%20Sun",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Xiangya Hospital, Central South University Changsha, Hunan, China."
}
},
{
"@type": "Person",
"name": "Yoshifumi Iwagami",
"url": "https://questionsmedicales.fr/author/Yoshifumi%20Iwagami",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Giant mucinous cystadenocarcinoma of ovary in a young woman: a case report and review of literature.",
"datePublished": "2024-05-28",
"url": "https://questionsmedicales.fr/article/38863641",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fonc.2024.1377042"
}
},
{
"@type": "ScholarlyArticle",
"name": "Successful Management of a Giant Mucinous Cystadenocarcinoma of the Ovary Through Laparotomy: A Case Report.",
"datePublished": "2024-05-16",
"url": "https://questionsmedicales.fr/article/38883143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.60474"
}
},
{
"@type": "ScholarlyArticle",
"name": "KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma.",
"datePublished": "2023-10-26",
"url": "https://questionsmedicales.fr/article/37916194",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2147/IJGM.S419235"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mucinous cystadenocarcinoma of the breast with bone metastases: First case report and literature review.",
"datePublished": "2023-12-21",
"url": "https://questionsmedicales.fr/article/38128508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000535649"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mucinous cystadenocarcinoma of the ovary in a 14-year-old girl: a case report and literature review.",
"datePublished": "2023-07-21",
"url": "https://questionsmedicales.fr/article/37479970",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12905-023-02551-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://questionsmedicales.fr/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://questionsmedicales.fr/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs épithéliales épidermoïdes et glandulaires",
"item": "https://questionsmedicales.fr/mesh/D009375"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs kystiques, mucineuses et séreuses",
"item": "https://questionsmedicales.fr/mesh/D018297"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cystadénocarcinome",
"item": "https://questionsmedicales.fr/mesh/D003536"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cystadénocarcinome - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cystadénocarcinome",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cystadénocarcinome",
"description": "Comment diagnostiquer un cystadénocarcinome ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés ?\nLe diagnostic précoce est-il possible ?\nQuelle est l'importance de l'imagerie ?",
"url": "https://questionsmedicales.fr/mesh/D003536?page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cystadénocarcinome",
"description": "Quels sont les symptômes courants ?\nLe cystadénocarcinome cause-t-il des nausées ?\nY a-t-il des symptômes spécifiques aux femmes ?\nLes symptômes varient-ils selon l'emplacement ?\nQuand consulter un médecin pour des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D003536?page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cystadénocarcinome",
"description": "Peut-on prévenir le cystadénocarcinome ?\nQuels facteurs de risque sont évitables ?\nLe dépistage précoce aide-t-il ?\nLes antécédents familiaux influencent-ils le risque ?\nY a-t-il des recommandations alimentaires ?",
"url": "https://questionsmedicales.fr/mesh/D003536?page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cystadénocarcinome",
"description": "Quels traitements sont disponibles ?\nLa chirurgie est-elle toujours nécessaire ?\nQuels médicaments sont utilisés en chimiothérapie ?\nLa radiothérapie est-elle efficace ?\nY a-t-il des traitements expérimentaux ?",
"url": "https://questionsmedicales.fr/mesh/D003536?page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cystadénocarcinome",
"description": "Quelles complications peuvent survenir ?\nLe cystadénocarcinome peut-il récidiver ?\nComment gérer la douleur liée au cancer ?\nY a-t-il des risques liés à la chimiothérapie ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D003536?page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cystadénocarcinome",
"description": "Quels sont les principaux facteurs de risque ?\nLe mode de vie influence-t-il le risque ?\nLes hormones jouent-elles un rôle ?\nY a-t-il des prédispositions génétiques ?\nL'exposition à des substances chimiques est-elle un risque ?",
"url": "https://questionsmedicales.fr/mesh/D003536?page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cystadénocarcinome ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie, la biopsie et les marqueurs tumoraux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, le scanner et l'IRM."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "CA-125 et CA 19-9 sont souvent mesurés pour évaluer le cystadénocarcinome."
}
},
{
"@type": "Question",
"name": "Le diagnostic précoce est-il possible ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est souvent difficile en raison de symptômes non spécifiques."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'imagerie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie aide à localiser la tumeur et à évaluer son extension."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur abdominale, ballonnements et perte de poids."
}
},
{
"@type": "Question",
"name": "Le cystadénocarcinome cause-t-il des nausées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nausées peuvent survenir en raison de la pression sur les organes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux femmes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes peuvent ressentir des douleurs pelviennes et des irrégularités menstruelles."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'emplacement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent de la localisation de la tumeur, comme ovarienne ou pancréatique."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes persistent ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le cystadénocarcinome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont évitables ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et maintenir un poids santé peuvent réduire certains risques."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce aide-t-il ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage peut aider à détecter des anomalies, mais n'élimine pas le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancers peuvent augmenter le risque de cystadénocarcinome."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en antioxydants peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent nécessaire pour enlever la tumeur, selon son stade."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés en chimiothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents comme le carboplatine et le paclitaxel sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie peut être utilisée pour réduire la taille de la tumeur ou soulager la douleur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques évaluent de nouvelles thérapies ciblées et immunothérapies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la propagation de la maladie et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Le cystadénocarcinome peut-il récidiver ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque de récidive après traitement, nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Comment gérer la douleur liée au cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et des thérapies complémentaires peuvent aider à gérer la douleur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques liés à la chimiothérapie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie peut entraîner des effets secondaires comme la fatigue et les nausées."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin et des antécédents familiaux de cancer."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et l'obésité augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les hormones jouent-elles un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres hormonaux peuvent contribuer au développement de tumeurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mutations génétiques, comme BRCA1 et BRCA2, augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des substances chimiques est-elle un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains produits chimiques peut augmenter le risque de cancer."
}
}
]
}
]
}
In April 2023, we successfully treated a 21-year-old patient afflicted with a rare giant cystadenocarcinoma, an extraordinarily large mucinous ovarian tumor that weighed nearly 25 kg. The preoperative...
Giant mucinous cystadenocarcinoma of the ovary is rarely described. Huge ovarian masses are mostly benign, but malignancy should be ruled out by investigations and clinical assessment. Here, we presen...
Ovarian cancer (OV) is the highest prevalent gynecologic tumor with complicated pathogenesis; high-grade serous ovarian cystadenocarcinoma (HGSOC) is the most epidemiological and malignant subtype of ...
Bioinformatic analysis with various databases was conducted in this study. In details, KRT19 expression was assessed using databases including The Cancer Genome Atlas (TCGA), Genotype-Tissue Expressio...
The expression of KRT19 was significantly upregulated in ovarian samples compared with normal controls. KRT19 expression was negatively associated with prognosis in OV, and further analysis revealed t...
This study demonstrated that KRT19 is a promising prognosis and diagnosis biomarker that determines cancer progression and is correlated with tumor immune cells infiltration in OV, suggesting being a ...
Mucinous cystadenocarcinoma (MCA) of the breast is an extremely rare type of breast carcinoma. Since its biological characteristics, treatment options, and clinical outcomes are unclear, there is a la...
We present a 54-year-old woman with a case of advanced MCA of the breast accompanied by a huge breast mass, lymph node involvement, and distant bone metastases. We diagnosed primary breast MCA through...
We present the first report worldwide of a rare case of MCA of the breast with a large local mass and bone metastasis. Our report adds to the limited literature on this rare breast cancer subtype and ...
Ovarian epithelial tumors are common in adults, and their peak incidence of onset is over 40 years of age. In children, most ovarian tumors are germ cell-derived, whereas epithelial tumors are rare an...
This report describes a case of a 14-year-old Chinese girl with ovarian mucinous cystadenocarcinoma. She was admitted with a small amount of bloody vaginal discharge during the past month. Magnetic re...
We report the first pediatric case of ovarian mucinous cystadenocarcinoma in China. Given the scarcity of reports addressing the clinical management of this condition, the present study provides a use...
Epithelial ovarian cancer is the most prevalent gynecological malignancy leading to mortality in adults but is an infrequent finding in children and adolescents. Most gynecological tumors found in fem...
Mucinous cystadenocarcinoma (MCA) is a very rare form of breast cancer that was first described in 1998. Only 33 cases of primary MCA, including our present case, have been reported thus far. As a con...
A 59-year-old woman presented with a breast lump in which mammography showed a well-defined nodule. Core needle biopsy (CNB) revealed several lesions lined by tall columnar cells with stratification a...
Our study presents the gene profile of an MCA case with no recurrence or metastatic tendency after 108 months of follow-up, and a review of the literature helps us better understand the clinical, path...
This study aimed to investigate the prognostic value of clinical features for cancer-specific survival (CSS) and metastasis in patients with pancreatic mucinous cystadenocarcinoma (MCAC). We further c...
We screened patients diagnosed with pancreatic MCAC from Surveillance Epidemiology and End Results (SEER) database. Kaplan-Meier curves were used to determine the CSS time. Univariate and multivariate...
Multivariate Cox analysis revealed that age, primary site, grade, and radiotherapy were independent prognostic factors associated with CSS. Multivariate logistic regression analysis revealed that surg...
We established a nomogram that could determine the 3- and 5-year CSS, which could evaluate individual clinical outcomes and provide individualized clinical decisions....
Ovarian cancer is the second most prevalent gynecologic malignancy, and ovarian serous cystadenocarcinoma (OSCA) is the most common and lethal subtype of ovarian cancer. Current screening methods have...
Ovarian cancer (usually ovarian serous cystadenocarcinoma, or OV) is the fifth leading cause of cancer-related deaths in women, with more than 184,000 deaths reported worldwide annually, and is a high...